Antliabio110 - A novel long-acting peptide-based therapeutic for the treatment of resistant hypertension (rHT)
Antliabio 111 - A novel long-acting peptide-based therapeutic for the treatment of pulmonary arterial hypertension (PAH)
Antliabio 112 - A novel long-acting peptide-based therapeutic for the treatment of chronic heart failure (HFpEF and HFrEF)
Antliabio210 - A novel long-acting peptide-based therapy for the treatment of multiple cardiovascular, pulmonary, and metabolic diseases
Copyright © 2023 Antlia Bioscience, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.